Medication Management for Ichthyosis Vulgaris

First-Line Topical Therapy

The British Journal of Dermatology recommends starting with topical keratolytics containing urea (10-20% concentration) applied twice daily as first-line therapy, combined with frequent emollient application, as this approach provides superior efficacy in reducing scaling and hyperkeratosis compared to emollients alone 1, 2
Urea is the most commonly used and effective keratolytic agent for ichthyosis vulgaris, with concentrations of 10% or higher required for keratolytic effect 1, 2
Apply urea 10-20% once or twice daily to affected areas, with the option to increase concentration up to 40% for localized areas of thick scale or hyperkeratosis, such as joints or palmoplantar regions 1, 2, 3
Avoid application on the face, flexures, and areas with fissuring due to risk of irritation, burning, and stinging 1, 3

Apply emollients at least twice daily to all affected areas, ideally immediately after bathing to lock in moisture and improve skin hydration through occlusion and lubrication 1, 3, 4
Bathe daily in lukewarm water for 30 minutes or more using mild soaps or soap-free cleansers 4
Apply emollients immediately after bathing while skin is still damp to maximize hydration 1, 3, 4

Tazarotene (0.05-0.1%) is recommended as first-line topical retinoid to reduce scaling or skin thickening when keratolytics alone are insufficient 2
Apply tazarotene once daily, typically at bedtime, to affected areas, and start with lower concentrations (0.025% or 0.05%) to minimize irritation 2, 5
Common side effects of tazarotene include erythema, peeling, scaling, burning, and dryness 5
Strictly avoid tazarotene in pregnancy (Category C) and women planning pregnancy 2, 5

Acitretin is the preferred systemic retinoid when topical therapy fails to adequately control severe ichthyosis vulgaris, based on EMA approval for congenital ichthyoses, established efficacy, and favorable long-term safety profile 2, 4
Reserve systemic retinoids for patients with severe disease significantly impacting quality of life who have failed topical therapy 2, 4
Systemic retinoids require strict pregnancy prevention and monitoring for side effects 2

Never use salicylic acid or lactic acid in children under 2 years due to systemic toxicity risk 1, 2
Do not apply keratolytics to face, flexures, or fissured areas due to irritation risk 1, 3
Avoid topical retinoids during pregnancy 2, 5

Psychological support should begin early and continue throughout life for both patients and family members, as ichthyosis significantly impacts quality of life 4